A clinic in Arapahoe County is exploring new ways to help patients by offering ketamine-assisted psychotherapy.
The U.S. Food and Drug Administration recently expanded approval of the nasal spray SPRAVATO, a ketamine-derived drug, as a treatment for depression. A clinic in Denver is looking to help those ...
The Food and Drug Administration (FDA) approved Johnson & Johnson’s ketamine-derived nasal spray to help millions of U.S.
A new study has found small amounts of liquid ketamine administered in a clinical setting can significantly reduce symptoms ...
An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a ...
Respondents who said they used other drugs recreationally were also likelier to say they used ketamine during the past year ...
Researchers at the University of Virginia Brain Institute and UVA School of Medicine will conduct a trial to see if the ...
The Food and Drug Administration (FDA) has approved Spravato, a nasal spray developed by Johnson & Johnson, as a standalone ...